John Lister
AHN Cancer Institute-Hematology at Mellon Pavilion
Office
(412) 578-4484
Fax (412) 578-3536 4815 Liberty Avenue, Suite MP322 Pittsburgh, PA 15224Call today!
Primary Specialty
Hematologist
Practice
AHN Cancer Institute-Hematology at Mellon Pavilion
Gender
Male
Education
Queens University
Training
Royal Victoria Hospital McGill University, Royal Victoria Hospital McGill University, Royal Victoria Hospital McGill University
Certification
American Board of Internal Medicine-Medical Oncology, American Board of Internal Medicine-Hematology
About
John Lister
Dr. Lister is Chief of the Division of Hematology and Cellular Therapy, AHN Cancer Institute. He is an experienced transplant physician who participated in his first bone marrow transplant in 1979. Since that time, he has been involved in more than a thousand transplants and has contributed to many clinical studies and made original contributions in the literature. Dr. Lister received his initial exposure to marrow transplantation as a trainee at McGill University and received further training at the Fred Hutchinson Cancer Research Center in Seattle. Subsequently, as Terry Fox Fellow of the National Cancer Institute of Canada, he received additional clinical and laboratory training in marrow transplantation at the Ontario Cancer Institute/Princess Margaret Hospital at the University of Toronto. He returned to McGill and actively participated in transplant for the next five years before accepting a position in the Division of Hematology and Bone Marrow Transplantation at The University of Pittsburgh. In 1997, he joined the faculty at West Penn Hospital. Dr. Lister is a Professor of Medicine, Temple University School of Medicine, and serves on numerous scientific and administrative committees, including the Lymphoma Committee of the CIBMTR. He is a member of the Board of Trustees for the Leukemia and Lymphoma Society of Western Pennsylvania.Services
lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease
Business Hours
Monday:10:00 AM - 4:00 PM
Tuesday:10:00 AM - 4:00 PM
Wednesday:10:00 AM - 4:00 PM
Thursday:10:00 AM - 4:00 PM
Friday:10:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed